Antimetabolites: all 7,305 studies that test it
Page 38 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS MutationTerminatedNCT04034173Phase 2
- Biomarker Guided Treatment in DLBCLStatus unknownNCT04025593Phase 2
- Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain TumorsCompletedNCT04023669Phase 1
- A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)TerminatedNCT04022876Phase 1
- PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT04022785Phase 1
- Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCLCompletedNCT04022005Phase 2
- Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal InsufficiencyStatus unknownNCT04020328Phase 4
- Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04018937Phase 2
- Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled StudyStatus unknownNCT04012918Phase 2
- Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no SymptomsStatus unknownNCT04012294Phase 3
- a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma PatientsStatus unknownNCT04008888Not applicable
- Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT04004871Phase 2
- A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTCStatus unknownNCT04004234Phase 1/2
- Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid TumorsTerminatedNCT03992326Phase 1
- Second Line Treatment With Nal-IRI and S1 in Pancreatic CancerStatus unknownNCT03986294Phase 2
- Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNCT03983824Phase 1
- Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced CholangiocarcinomaStatus unknownNCT03982680Phase 2
- Evaluation of Polychemotherapy With XELOXIRI-3 in Elderly or Frail Patients With Advanced Pancreatic AdenocarcinomaTerminatedNCT03974854Phase 2
- Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer PatientsCompletedNCT03974594Phase 1
- Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or RefractorySuspendedNCT03969446Phase 1
- Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid TumorsActive, not recruitingNCT03967223Phase 2
- Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic TransplantCompletedNCT03961919Phase 2
- The Effect of D-cycloserine on Emotional ProcessingCompletedNCT03961464Not applicable
- Metronomic Chemotherapy With Capecitabine for Pancreatic CancerStatus unknownNCT03959150Phase 2/3
- Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast CancerCompletedNCT03958721Phase 1
- Pemetrexed for the Treatment of ChordomaCompletedNCT03955042Phase 1
- Leflunomide in Treating Patients With High-Risk Smoldering Multiple MyelomaWithdrawnNCT03952832Phase 2
- Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric CancerStatus unknownNCT03950141Phase 2
- Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)Active, not recruitingNCT03948867Phase 2
- Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)Active, not recruitingNCT03944772Phase 2
- Azacytidine During Anti-tuberculosis TherapyWithdrawnNCT03941496Phase 1/2
- Adjunctive D-Cycloserine in Major Depressive DisorderCompletedNCT03937596Phase 2
- Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML PatientsWithdrawnNCT03932318Phase 1/2
- A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerCompletedNCT03929666Phase 2
- Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic CancerStatus unknownNCT03929094Phase 2
- Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th SalvageTerminatedNCT03926624Phase 3
- Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast CancerStatus unknownNCT03923166Phase 2
- Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance TherapyStatus unknownNCT03920813Phase 4
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaActive, not recruitingNCT03914625Phase 3
- Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's DiseaseCompletedNCT03909646Phase 4
- High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03908333Phase 1/2
- Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle GlaucomaStatus unknownNCT03904381Phase 4
- CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid LeukemiaTerminatedNCT03904251Phase 1
- Tegio Consolidation Therapy for NPC Patients With High Risk of MetastasisStatus unknownNCT03904225Phase 2
- Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid LeukemiaCompletedNCT03900949Phase 1
- Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse GeneticsActive, not recruitingNCT03897127Phase 3
- PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISISCompletedNCT03895671Phase 2
- Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin LymphomaCompletedNCT03892421Phase 1/2
- The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric CancerStatus unknownNCT03889626Phase 3
- Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast CancerCompletedNCT03888677Phase 3
- Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT03885219Phase 2
- Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based TherapyCompletedNCT03883919Phase 1
- CPX-351+GO in Subjects 55 Years Old, or Older, With AMLTerminatedNCT03878927Phase 1
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Hepatic Artery Infusion Pump for NPC Liver MetastasesCompletedNCT03876574Phase 1
- Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid TumorsActive, not recruitingNCT03875287Phase 1
- Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.Active, not recruitingNCT03869892Phase 3
- A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung CancerTerminatedNCT03866980Phase 3
- Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaActive, not recruitingNCT03862157Phase 1/2
- Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBCTerminatedNCT03858972Phase 2
- Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver MetastasesActive, not recruitingNCT03856658Phase 2
- Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）Status unknownNCT03855384Phase 3
- Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDSStatus unknownNCT03855371Phase 1
- Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic CancerStatus unknownNCT03850769Phase 2
- Evaluation the Effect of Using of Apical Matrix With Apexification Procedure on Apical Healing of Necrotic Immature TeethCompletedNCT03849222Phase 2/3
- Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid LeukemiaActive, not recruitingNCT03844815Phase 1
- Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal CancerWithdrawnNCT03843853Phase 2
- Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell TransplantationActive, not recruitingNCT03843528Phase 1
- GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03840421Phase 3
- TNT to Increase the Clinical Complete Response Rate for Distal LARCActive, not recruitingNCT03840239Phase 2
- Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaCompletedNCT03837977Phase 2
- DLCL002 Protocol for Patients With High Risk Aggressive B-cell LymphomaStatus unknownNCT03837873Phase 2
- A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese SubjectsCompletedNCT03836599Phase 1
- The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract AdenocarcinomaCompletedNCT03830606Phase 2
- QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.Active, not recruitingNCT03828227Phase 3
- Randomized, Single-dose, Crossover Study of 4 Decitabine and Tetrahydrouridine (EPI01) Formulations in Healthy SubjectsCompletedNCT03828084Phase 1
- CPX-351 Plus Enasidenib for Relapsed AMLActive, not recruitingNCT03825796Phase 2
- Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AMLStatus unknownNCT03825367Phase 1/2
- A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )Status unknownNCT03825328Phase 2
- S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung CancerCompletedNCT03823118Phase 2
- Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAAStatus unknownNCT03821987Not applicable
- Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant ChemotherapyStatus unknownNCT03821454Not applicable
- Effects of RP101 in Post-menopausal Women With Dry Eye SyndromeCompletedNCT03821415Phase 2
- A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLCActive, not recruitingNCT03819465Phase 1
- Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic CancerStatus unknownNCT03815461Phase 2
- Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitisCompletedNCT03815448Not applicable
- Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric AdenocarcinomaCompletedNCT03814759Phase 2
- The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian CancerStatus unknownNCT03814447Early Phase 1
- RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)Status unknownNCT03813641Phase 2
- A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or LeiomyosarcomaCompletedNCT03810976Phase 2
- A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue SarcomaCompletedNCT03809637Phase 2
- Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas CancerCompletedNCT03807999Phase 2
- FUSCC Refractory TNBC Umbrella (FUTURE)Status unknownNCT03805399Phase 1/2
- Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric AdenocarcinomaStatus unknownNCT03801668Phase 3
- MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian CancerStatus unknownNCT03799913Early Phase 1
- Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal CancersCompletedNCT03799731Phase 2
- High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03797443Phase 1/2
- Lenalidomide, Rituximab, Gemcitabine, Oxaliplatin and Dexamethasone in Relapse and Refractory DLBCLStatus unknownNCT03795571Phase 1
- Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based RegimenWithdrawnNCT03792503Phase 4
- PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT03791905Phase 2